Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate
Open Access
- 1 January 2011
- journal article
- letter
- Published by S. Karger AG in European Neurology
- Vol. 65 (4), 231-232
- https://doi.org/10.1159/000324028
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Multiple sclerosis associated fatigue during natalizumab treatmentJournal of the Neurological Sciences, 2009
- Prevalence and Severity of Multiple-Sclerosis-Associated Fatigue in Treated and Untreated PatientsEuropean Neurology, 2007
- A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisThe New England Journal of Medicine, 2006
- Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?Journal of Neurology, Neurosurgery & Psychiatry, 2006
- The effect of immunomodulatory treatment on multiple sclerosis fatigueJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parametersMultiple Sclerosis Journal, 2002
- Fatigue in MS is associated with specific clinical featuresActa Neurologica Scandinavica, 1995
- The Fatigue Severity ScaleArchives of Neurology, 1989